SBIR/STTR Research Award
CARDIOVASCULAR PATCH PROTECTION SYSTEM USING A DURABLE, SELF-SEALING MATERIAL
Award amount
$1,464,111Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SOLINAS MEDICAL INC.
- Proposal award date
- 2017-05-15
- Contract end date
- 2020-03-31
- UEI
- Not reported
- Solicitation number
- PAR14-088
- Topic code
- NHLBI
Research abstract
Project Summary
This Small Business Innovation Research Phase II project supports the development of an instantly sealing
vessel protection platform with enhanced durability against needle sticks While Medicare spends over $
billion annually on the treatment for end stage renal disease greater than of its budget $ billion is spent
treating preventable access related complications Many of these complications are directly or indirectly a
result of repeated large bore needle cannulations and methods used to manage the access site after
treatment The technology will be the first product to prophylactically serve the AV fistula market and creates
an untapped market with greater than $ million in the U S This project will expand knowledge on methods
to improve vascular access designed to address secondary complications instead of relying on conventional
approaches of treating the complications after they have occurred Success of this research will increase
understanding on methods of creating materials for applications where closure and re traversable access is
desired
The primary value proposition of the proposed technology is to offer a prophylactic means of protecting AV
access systems that undergo rapid degeneration by reinforcing the site of repeated cannulation In an effort to
support our commercialization launch the objective of the scientific aims is to demonstrate the clinical safety
and effectiveness of the patch system in addressing persistent access related complications Specifically the
scientific aim is to conduct a prospective clinical trial to evaluate the safety and efficacy of the patch
technology in patients undergoing hemodialysis with an AVF Project Narrative
This Small Business Innovation Research Phase II project supports the development of a vascular
protection platform While Medicare spends over $ billion annually on the treatment of chronic kidney
failure representing of its budget $ billion is spent on treating preventable secondary complications that
stem from access related complications By protecting the vessel there is a potential to improve patient
outcome and support clinical and healthcare policy objectives
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY
- Head Up CPR and Aortic Occlusion to Improve Survival after Refractory Cardiac Arrest
- Free-Breathing Dynamic Cardiopulmonary Function Imaging System to use with Xenon MRI
- The Next Wave of Asthma Therapeutics
- Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications